Continued from page 13 – Virus Cancer Programadditional monkey virus and an ape virus. How thesethree viruses contaminated Gallo's lab is unknown.However, George Todaro, an equally famous virologist,was quoted as saying, "You can get three viruses into avirus preparation easily just by being sloppy, and Gallohad plenty of sloppy people." (See John Crewdson'sScience Fictions: A Scientific Mystery, A MassiveCover-Up, and the Dark Legacy of Robert Gallo, p20).As late as 1986 Max Essex of Harvard "discovered" anew human AIDS retrovirus that he found in the bloodof healthy Africans. Eventually this virus also proved tobe a monkey virus that originated in a nearby primatecolony. Somehow the animal virus had worked its wayinto Essex's lab and blood samples.Interestingly, both Gallo and Essex, the two foremostAmerican AIDS researchers, were the leadingproponents of the African green monkey theory ofAIDS. Now the more widely accepted theory, proposedby Beatrice Hahn (who worked in Gallo's lab when heproposed the green monkey theory), claims the virustraces back to chimpanzees in the African wild. Hahnhas never <strong>com</strong>mented on the primate contaminationproblems in Gallo's lab.Could the primate "ancestors" of the RNA-type HIVretrovirus and the DNA-type herpes saimiri-like KSherpes virus have accidentally-or deliberately-workedtheir way into the experimental hepatitis B vaccine?The extremely high incidence of both these "new"viruses in the gay men, who volunteered for thehepatitis experiments, certainly provide enoughadditional circumstantial evidence to make the manmadetheory of AIDS as plausible as the monkey out ofAfrica theory.The gay hepatitis B experiments (1978-1981)The experimental hepatitis B vaccine injected into gayswas unlike any other vaccine previously made. It wasdeveloped in chimpanzees and manufactured in a yearlongprocess of sterilization and purification of thepooled blood of 30 gay men who were hepatitis B viruscarriers. During the first gay experiment (November1978-October 1979) at the New York Blood Center,there was great concern that the vaccine might becontaminated.According to June Goodfield's Quest for the Killers, p86, "This was no theoretical fear, contamination havingbeen suspected in one batch made by the NationalInstitutes of Health, though never in Merck's." The menwere given three inoculations of the vaccine over aperiod of time. The vaccine was successful with 96% ofthe men developing protective antibodies against thehepatitis B virus.-14- Traditional African Clinic December 2006It has been assumed by some that these men wereimmunosuppressed due to their promiscuity and historyof venereal disease. Although the young men in thestudy were indeed "promiscuous" (this was arequirement for entrance into the study), they were inexcellent health. Despite many previous sexual partners,these volunteers had never contracted evidence ofhepatitis B infection. Furthermore, immunosuppressedpeople often do not respond to the vaccine.The men in the Manhattan experiment had the highestrate of HIV ever recorded for that time period (over 20%of the men were HIV-positive in 1981, and over 40% in1984). Therefore, it must be assumed that many, if notmost, of these men eventually died of AIDS. The actualnumber of AIDS deaths among the men in theexperiment has never been revealed, nor have theirmedical records been studied. Attempts to secure thisinformation have been rebuffed due to the "confidential"nature of the experiment.The end of the VCP and the birth of AIDSBy 1980 the VCP came to an inglorious end with theinability to prove that viruses were involved in humancancer. More than any other program it built up the fieldof animal retrovirology, which led to a more <strong>com</strong>pleteunderstanding of how cancer and immunosuppressiveretroviruses caused disease in humans. The VCP was thebirthplace of genetic engineering, molecular biology,and the human genome project. I am convinced the VCP(and not Africa) is the birthplace of HIV/AIDS as well.As the VCP was winding down in the late 1970s, the gayexperiments began in New York City, and continued inother cities, such as San Francisco and Los Angeles.These cities would rapidly be<strong>com</strong>e the three primaryepicenters of the new and unprecedented "gay-relatedimmune deficiency syndrome," later known as AIDS.The introduction of HIV and the KS herpes virus intogay men (along with some "novel" and now-patentedmycoplasmas discovered at the Armed Forces Instituteof Pathology) miraculously revived the career of RobertGallo and made him the most famous virologist in theworld, and, of course, turned the "failure" of the VCPinto a triumph.When Gallo's blood test for HIV became available in themid-1980s, the New York Blood Center's stored gayblood specimens were reexamined. Most astonishing isthe fact that 20% of the gay men who volunteered for thehepatitis B experiment in Manhattan were discovered tobe HIV-positive in 1980 (one year before the AIDSepidemic became "official" in 1981). This signifies thatManhattan gays in 1980 had the highest incidence ofContinued on page 15
Continued from page 14- Virus Cancer ProgramHIV anywhere in the world, including Africa, thesupposed birthplace of HIV and AIDS. In addition, in1982, in an AIDS trial in New York City one out offive gay men (20%) tested positive for the new KSherpes-8 virus when stored blood samples were reexaminedby epidemiologists at the NCI in 1999.Rarely mentioned by AIDS historians is the fact thatthe New York Blood Center established a chimp viruslaboratory for viral vaccine research in West Africa in1974. One of the purposes of VILAB II, inRobertsfield, Liberia, was to develop the hepatitis Bvaccine in chimps. The lab also prides itself byreleasing "rehabilitated" (but virus-infected) chimpsback into the wild.Also conveniently forgotten in the history of AIDS isLEMSIP (The Laboratory for Experimental Medicineand Surgery), the primate colony located outside NewYork City. For many years, until disbanded in 1997,LEMSIP supplied scientists with primates and primateparts (and unknown primate viruses) for transplantationand virus research. Primate parts (and primate viruses)were experimentally transplanted in human beings asearly as the 1960s.LEMSIP was also affiliated with New York UniversityMedical Center, where the first cases of AIDSassociatedKaposi's sar<strong>com</strong>a were discovered in 1979.Researchers at NYU were also heavily involved in thedevelopment of the experimental hepatitis B vaccineused in gays. According to Leonard Horowitz, authorof Emerging Viruses: AIDS and Ebola, NYU MedicalCenter received government grants and contractsconnected with biological warfare research beginningin 1969.The evidence gathered here is a tiny fraction of thecircumstantial evidence supporting the man-madetheory of AIDS. Scientists have a long and provenhistory of covertly experimenting on people "in thename of science." Anyone who takes the time to studythe reports of the VCP will recognize that humanexperimentation with cancer viruses was undoubtedlyconsidered and ultimately desired. Is the fact thatHIV/AIDS appeared within a decade of this dangerouscancer virus experimentation a coincidence? ShouldAIDS be blamed on human sexuality, gays, blacks, andmonkeys? I think not.There is nothing wrong or unpatriotic or"conspiratorial" in presenting the vast amount ofevidence that connects out-of-control animal cancerexperimentation and biowarfare research with the birthof AIDS. What is wrong, however, is the unwillingnessof the scientific establishment and the media and the public tolook at it.Dr. Cantwell is a retired dermatologist and has written twobooks on the man-made origin of AIDS; and two books on theinfectious origin of cancer, all published by Aries RisingPress, PO Box 29532, Los Angeles, CA 90029,(www.ariesrisingpress.<strong>com</strong>).☻☻☻☻☻☻☻☻☻☻☻☻Roche's Tamiflu to AddWarning on Psychiatric Risks(Update 1)By Catherine LarkinNov. 13, 2006 (Bloomberg) -- Roche Holding AG's Tamifluflu treatment must carry information warning of potentialrisks of psychiatric side effects, U.S. regulators said. TheFood and Drug Administration approved a labeling revisionto include information on those risks after reports of selfinjuryand mutilation among Japanese patients using the drug,the agency said today in an e-mailed statement. Most of theseside effects were reported in children.The new label will urge doctors to monitor patients withinfluenza for signs of abnormal behavior immediately afterthey begin taking Tamiflu. While the “relative contribution ofthe drug to these events is not known,” the regulators said thelabeling revision is intended to mitigate the potential risks.Roche, based in Basel, Switzerland, said in a statement that itis <strong>com</strong>mitted to working with regulators to ensure that thedrug's labeling accurately reflects reports of adverse events.To contact the reporter on this story: Catherine Larkin inWashington at clarkin4@bloomberg.net.http://www.bloomberg.<strong>com</strong>/apps/news?pid=20601087&sid=aLUqmToDWYS8&refer=home#☻☻☻☻☻☻-15- Traditional African Clinic December 2006